Dec 9, 2025 07:56AM Simulations Plus responds to FDA draft guidance on streamlined safety studies

Dec 2, 2025 04:23AM Simulations Plus (SLP) Fairly Valued Given Modest FY26-27 Growth Estimates - Citizens

Dec 1, 2025 04:11PM Simulations Plus (SLP) Reports In-Line Q4 EPS, Misses on Revenue; Offers Guidance

Oct 29, 2025 08:31AM KeyBanc on Simulations Plus (SLP): 'Early Signs of Stability + Potential Recovery'

Oct 28, 2025 04:25AM Citizens Reiterates Simulations Plus (SLP) at Market Perform

Oct 22, 2025 07:51AM Simulations Plus reports preliminary fiscal 2025 revenue of $79.1 million

Sep 30, 2025 05:29AM TD Cowen Starts Simulations Plus (SLP) at Hold

Sep 5, 2025 05:44PM Robinhood, AppLovin, Emcor Group to be included in S&P 500 Index

Jul 29, 2025 07:51AM Simulations Plus validates AI drug design with Polish academy study

Jul 15, 2025 06:51AM Simulations Plus (SLP) PT Lowered to $20 at Stephens

Jul 15, 2025 06:16AM BTIG Reiterates Buy Rating on Simulations Plus (SLP)

Jul 15, 2025 05:17AM Citizens JMP Reiterates Market Perform Rating on Simulations Plus (SLP)

Jul 15, 2025 12:53AM KeyBanc Downgrades Simulations Plus (SLP) to Sector Weight

Jul 14, 2025 04:16PM Simulations Plus invests $1 million in clinical trial technology firm Nurocor

Jul 14, 2025 04:06PM Simulations Plus (SLP) Tops Q3 EPS by 20c; offers guidance

Jun 18, 2025 04:05PM Simulations Plus (SLP) Announces Rescheduling of Q3 Earnings Release

Jun 18, 2025 04:38AM Citizens JMP Reiterates Market Perform Rating on Simulations Plus (SLP)

Jun 12, 2025 06:28AM Simulations Plus (SLP) PT Lowered to $28 at Stephens

Jun 11, 2025 04:33PM Simulations Plus (SLP) Reports Prelim Q3 Results

May 15, 2025 07:50AM Simulations Plus (SLP) Releases DILIsym 11

Apr 4, 2025 05:09AM Simulations Plus (SLP) PT Lowered to $41 at BTIG

Apr 4, 2025 04:35AM Citizens JMP Reiterates Market Perform Rating on Simulations Plus (SLP)

Apr 3, 2025 04:10PM Simulations Plus (SLP) Tops Q2 EPS by 5c; offers guidance

Jan 24, 2025 05:35AM KeyBanc Highlights Simulations Plus (SLP) as the 'Best Way to Play a Recovery'; PT Raised to $37

Jan 8, 2025 06:33AM Oppenheimer Reiterates Outperform Rating on Simulations Plus (SLP)

Jan 7, 2025 04:10PM Simulations Plus (SLP) Tops Q1 EPS by 3c; offers guidance

Jan 3, 2025 08:42AM Oppenheimer Reiterates Outperform Rating on Simulations Plus (SLP)

Oct 30, 2024 08:33AM Simulations Plus (SLP) and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

Oct 24, 2024 05:42AM Simulations Plus (SLP) PT Lowered to $50 at BTIG

Oct 23, 2024 04:15PM Simulations Plus (SLP) Tops Q4 EPS by 2c, provides guidance

Aug 23, 2024 08:00AM Simulations Plus (SLP) Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions

Jul 29, 2024 02:05AM KeyBanc Starts Simulations Plus (SLP) at Overweight

Jul 16, 2024 02:01AM JMP Securities Starts Simulations Plus (SLP) at Market Perform

Jul 3, 2024 07:44AM Oppenheimer Reiterates Outperform Rating on Simulations Plus (SLP)

Jul 2, 2024 05:04PM After-hours movers: Tesla, First Foundation, Simulations Plus, and Rivian

Jul 2, 2024 04:10PM Simulations Plus (SLP) Tops Q3 EPS by 4c, Offers Guidance

Jun 28, 2024 07:11AM William Blair Starts Simulations Plus (SLP) at Outperform

Jun 13, 2024 09:00AM Simulations Plus (SLP) PT Raised to $56 at Craig-Hallum

Jun 13, 2024 06:25AM Simulations Plus (SLP) PT Raised to $65 at Oppenheimer

Jun 12, 2024 08:13AM Simulations Plus (SLP) Acquires Pro-ficiency